ASTHMA

External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?

Justin Travers¹, Suzanne Marsh¹, Mathew Williams¹, Mark Weatherall², Brent Caldwell¹, Philippa Shirtcliffe¹, Sarah Aldington¹, Richard Beasley³

¹ Medical Research Institute of New Zealand, Wellington, New Zealand
² Wellington School of Medicine and Health Sciences, Wellington, New Zealand
³ University of Southampton, Southampton, UK

Correspondence to:
Professor R Beasley
Medical Research Institute of New Zealand, PO Box 10055, Wellington, New Zealand; richard.beasley{at}mrinz.ac.nz

Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a given patient.

Aim: To calculate the proportion of individuals with asthma who would have been eligible for the major asthma RCTs from the data of a random community survey of respiratory health.

Methods: A postal survey was sent to 3500 randomly selected individuals aged 25–75 years. Respondents were invited to complete a detailed respiratory questionnaire and pulmonary function testing. Participants with current asthma were assessed against the eligibility criteria of the 17 major asthma RCTs cited in the Global Initiative for Asthma (GINA) guidelines.

Findings: A total of 749 participants completed the full survey, of whom 179 had current asthma. A median 4% of participants with current asthma (range 0–36%) met the eligibility criteria for the included RCTs. A median 6% (range 0–43%) of participants with current asthma on treatment met the eligibility criteria.

Interpretation: This study shows that the major asthma RCTs on which the GINA guidelines are based may have limited external validity as they have been performed on highly selected patient populations. Most of the participants with current asthma on treatment in the community would not have been eligible for these RCTs.

Abbreviations: COPD, chronic obstructive pulmonary disease; FEV₁, forced expiratory volume in 1 s; GINA, Global Initiative for Asthma; RCT, randomised controlled trial

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Airwaves

Wisia Wedzicha
Thorax 2007 62: 193. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Weatherall, M., Travers, J., Shirtcliffe, P. M., Marsh, S. E., Williams, M. V., Nowitz, M. R., Aldington, S., Beasley, R. (2009). Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 34: 812-818 [Abstract] [Full Text]  
• Rothwell, P. M (2009). Commentary: External validity of results of randomized trials: disentangling a complex concept. Int J Epidemiol 0: dyp305v1-dyp305 [Full Text]  
• van der Meer, V., Bakker, M. J., van den Hout, W. B., Rabe, K. F., Sterk, P. J., Kievit, J., Assendelft, W. J.J., Sont, J. K., for the SMASHING (Self-Management in Asthma Suppor, (2009). Internet-Based Self-management Plus Education Compared With Usual Care in Asthma: A Randomized Trial. ANN INTERN MED 151: 110-120 [Abstract] [Full Text]  
• Dekkers, O M, Elm, E v., Algra, A, Romijn, J A, Vandenbroucke, J P (2009). How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol 0: dyp174v1-dyp174 [Abstract] [Full Text]  
• Holgate, S., Bisgaard, H., Bjermer, L., Haahtela, T., Haughney, J., Horne, R., McIvor, A., Palkonen, S., Price, D. B., Thomas, M., Valovirta, E., Wahn, U. (2008). The Brussels Declaration: the need for change in asthma management. Eur Respir J 32: 1433-1442 [Abstract] [Full Text]  
• Wijesinghe, M, Perrin, K, Harwood, M, Weatherall, M, Beasley, R (2008). The risk of asthma mortality with inhaled long acting {beta}-agonists. Postgrad. Med. J. 84: 467-472 [Abstract] [Full Text]  
• Michils, A., Baldassarre, S., Van Muylem, A. (2008). Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur Respir J 31: 539-546 [Abstract] [Full Text]  
• Travers, J., Marsh, S., Aldington, S., Williams, M., Shirtcliffe, P., Pritchard, A., Weatherall, M., Beasley, R. (2007). Reference Ranges for Exhaled Nitric Oxide Derived from a Random Community Survey of Adults. Am. J. Respir. Crit. Care Med. 176: 238-242 [Abstract] [Full Text]  
• Town, I. (2007). Applying the results of randomised control trials on asthma. Thorax 62: 195-196 [Full Text]